BTE Technologies, LLC

BTE Technologies, LLC manufactures specialized rehabilitation and medical evaluation equipment for federal healthcare customers, operating exclusively as a prime contractor on GSA Federal Supply Schedules and direct purchase orders from the Department of Veterans Affairs, Department of Defense, and Army Medical Command. The company is a for-profit limited liability partnership headquartered in Hanover, Maryland, and a subsidiary of Emerson Electric Co.'s White-Rodgers Division. BTE competes in full-and-open federal procurement with no set-aside designations across its prime footprint, though individual awards occasionally carry Total Small Business set-aside markings.

BTE's capability portfolio centers on sensory integration devices, occupational therapy systems, neuromuscular analyzers, and functional rehabilitation equipment. Representative recent work includes a $35.2 thousand delivery order from Veterans Integrated Service Network 5 in July 2026 for a BTE Simulator II system under the GSA Medical Equipment and Supplies schedule (FSS-65-II-A), a $71.5 thousand order from Veterans Integrated Service Network 7 for a PRIMUS OS Chair also under FSS-65-II-A, and a $54.2 thousand award from Veterans Integrated Service Network 22 for a full-suite testing system completed in August 2026. Earlier awards included a $74.5 thousand Defense Health Agency delivery order for a PRIMUS RS occupational therapy interactive rehabilitative system placed in May 2023 and a $67.3 thousand Army Medical Command purchase order for a PRIMUS RS neuromuscular analyzer delivered to Fort Drum in November 2022.

Customer concentration skews heavily toward military and VA healthcare networks. The Department of the Army Medical Command anchors the portfolio with 58 awards and $2.5 million in combined potential value, followed by the Department of the Navy Bureau of Medicine and Surgery with 36 awards and $832 thousand. By dollars, however, Veterans Integrated Service Network 12 dominates with 5 awards carrying $9 million in combined potential value — a stark disparity signaling a small number of high-value orders from that single facility. Across the five top customers named in the award-count ranking, concentration reaches 54% of total awards; the top customers by dollar value cover 70% of combined potential value, with the VA network's concentration visible in that second ranking.

BTE operates primarily through two GSA Federal Supply Schedules: the Federal Supply Schedule V797P4031A (91 task orders, $3.2 million combined potential value) and the Medical Equipment and Supplies schedule (63 task orders, $3.3 million combined potential value), with a smaller footprint on Federal Supply Schedule V797P3325J (37 task orders). Award volume has declined sharply — four awards in 2022, three in 2023, two in 2024, one in 2025, and three in 2026 — but does not yet signal market exit, with recent work flowing through the fourth quarter of 2026. Only four awards face ultimate completion within the next twenty-four months, carrying combined potential value of $133 thousand, presenting minimal recompete exposure in the near term. BTE holds no subcontract footprint and does not appear in the source data as a supplier to other federal primes, operating entirely on its own GSA schedule authorizations and direct orders to military treatment facilities and VA networks across the continental United States.